A tightly controlled system of checks and balances ensures that a powerful tumor suppressor called p53 keeps a tight lid on unchecked cell growth but doesn’t wreak havoc…

A comprehensive overview that explores the prospects and progress of synthetic inhibitors to target cell cycle kinases in cancer forecasts that “novel compounds with increased potency, improved kinase specificity…

A new study by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the…

Researchers at Ben-Gurion University of the Negev (BGU) have discovered that gene mutations that once helped humans survive may increase the possibility for diseases, including cancer.

The…

New research suggests that for some patients with cancer, especially brain tumors and small-cell-lung cancer, the first manifestation is a psychiatric symptom.

The results indicate that in the month…

Australian scientists have developed a “Trojan horse” therapy to combat cancer, using a bacterially derived nano cell to penetrate and disarm the cancer cell before a second nano cell kills…

Europe is aiming to reduce its cancer deaths by 15 percent by 2020 and needs to double screenings to prevent mortality rates climbing as the population…

Researchers at Children’s Hospital Boston have isolated a potent inhibitor of tumor metastasis made by tumor cells, one that could potentially be harnessed as a cancer treatment. Their findings were…

Using a “chemical nose” array of nanoparticles and polymers, researchers at the University of Massachusetts Amherst have developed a fundamentally new, more effective way to differentiate not only between healthy…

Women of lower socioeconomic status (SES) are less likely to survive after a cancer diagnosis largely due to unhealthy lifestyle factors, such as smoking, that are more common among less…

A new study published by University of Leicester researchers has found “convincing evidence” that cannabis smoke damages DNA in ways that could potentially increase the risk of cancer development in humans.

Using…

Chemists at the University of California, Santa Cruz, have developed novel compounds that show promise for photodynamic cancer therapy, which uses light-activated drugs to kill tumor cells.

The new…

Most patients with a form of eye cancer called choroidal melanoma want to undergo a genetic test that can predict their likely outcome, a small study suggests.

Moreover, researchers found,…

Researchers at Nationwide Children’s Hospital and Johns Hopkins University have discovered that delivering a small molecule that is highly expressed in normal tissues but lost in diseased cells can result…

Women continue to be under-enrolled in cancer clinical trials, according to a new review, published in the July 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society.…

Corrupt lifestyles and vices go hand in hand; each feeds the other. But even the worst miscreant needs customary societal amenities to get by. It’s the same with cancer…

Most cancers are rare in people with Down syndrome, whose overall cancer mortality is below 10 percent of that in the general population. Since they have an extra…

In technology that promises to one day allow drug delivery to be tailored to an individual patient and a particular cancer tumor, researchers at…

A ground-breaking Canada-wide clinical trial led by Dr. Katherine Borden, at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal,…

Nearly one-third of cancer research published in high-impact journals disclosed a conflict of interest, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

A new analysis finds that a considerable number of clinical cancer studies published in respected medical journals have financial connections to pharmaceutical companies. Published in the June 15,…

Over the next 20 years, the number of new cancer cases diagnosed annually in the United States will increase by 45 percent, from 1.6 million in…

The number of new cancer cases diagnosed each year will jump 45 percent in the next two decades to 2.3 million up from 1.6 million in 2010, affecting…

The diagnosis of cancer is a jarring experience. Patients face a battery of diagnostic tests, clinic visits, specialist consultations and intense treatments that drastically affect their quality of…

Cancer patients can survive longer under treatments based on their individual genetic profiles, according to a nationwide study released jointly today by Phoenix-area healthcare organizations.

The study shows that molecular…